help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2002-0128
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyoshi, K.
Right arrow Articles by Robinson, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyoshi, K.
Right arrow Articles by Robinson, G. W.
Molecular Endocrinology 16 (12): 2892-2901
Copyright © 2002 by The Endocrine Society

Mammary Epithelial Cells Are Not Able to Undergo Pregnancy-Dependent Differentiation in the Absence of the Helix-Loop-Helix Inhibitor Id2

Keiko Miyoshi, Barbara Meyer, Peter Gruss, Yongzhi Cui, Jean-Pierre Renou, Fanta V. Morgan, Gilbert H. Smith, Moshe Reichenstein, Moshe Shani, Lothar Hennighausen and Gertraud W. Robinson

Laboratory of Genetics and Physiology (K.M., Y.C., J.-P.R., F.V.M., M.S., L.H., G.W.R.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, and Basic Research Laboratory (G.H.S.), National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; Department of Biochemistry (K.M.), School of Dentistry, The University of Tokushima, Tokushima 770-8504, Japan; Department of Molecular Cell Biology (B.M., P.G.), Max Planck Institute of Biophysical Chemistry, Goettingen 37077, Germany; Institut National de la Recherche Agronomique (J.-P.R.), Jouy-en-Josas Cedex 78280, France; and Agricultural Research Organization (M.R., M.S.), Volcani Center, Bet Dagan 50250, Israel

Address all correspondence and requests for reprints to: Gertraud Robinson, Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 8, Room 101, 8 Center Drive, Bethesda, Maryland 20892-0822. E-mail: traudl{at}nih.gov.

Mammary alveolar development during pregnancy is triggered by hormone signals. The prolactin receptor/Jak2/signal transducer and activator of transcription (Stat) 5 signal transduction pathway is the principal mediator of these cues and alveolar development is abrogated in its absence. The loss of the basic helix-loop-helix protein inhibitor of differentiation (Id)2 results in a similar defect. To investigate the role of Id2 in mammary epithelium, we performed structural and molecular analyses. Id2-null mammary epithelial cells were unable to form alveoli; the epithelial architecture was disorganized and dissimilar from early stages of alveologenesis in wild-type glands. The epithelial cells retained the ductal marker Na-K-Cl cotransporter (NKCC)1. Nuclear localization of Stat5a and down-regulation of NKCC1 was observed in some areas, indicating a limited response to pregnancy signals. The differentiation status of Id2-null tissue at term was further characterized with cDNA microarrays enriched in mammary specific sequences (mammochip). Some of the early differentiation markers for mammary epithelium were expressed in the Id2-null tissue, whereas genes that are expressed at later stages of pregnancy were not induced. From these results, we conclude that, in the absence of Id2, mammary epithelial development is arrested at an early stage of pregnancy.




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. D. Aupperlee, A. A. Drolet, S. Durairaj, W. Wang, R. C. Schwartz, and S. Z. Haslam
Strain-Specific Differences in the Mechanisms of Progesterone Regulation of Murine Mammary Gland Development
Endocrinology, March 1, 2009; 150(3): 1485 - 1494.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Fernandez-Valdivia, A. Mukherjee, C. J. Creighton, A. C. Buser, F. J. DeMayo, D. P. Edwards, and J. P. Lydon
Transcriptional Response of the Murine Mammary Gland to Acute Progesterone Exposure
Endocrinology, December 1, 2008; 149(12): 6236 - 6250.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. N. Johnstone, P. S. Mongroo, A. S. Rich, M. Schupp, M. J. Bowser, A. S. deLemos, J. W. Tobias, Y. Liu, G. E. Hannigan, and A. K. Rustgi
Parvin- Inhibits Breast Cancer Tumorigenicity and Promotes CDK9-Mediated Peroxisome Proliferator-Activated Receptor Gamma 1 Phosphorylation
Mol. Cell. Biol., January 15, 2008; 28(2): 687 - 704.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Zhao, C. Johansson, T. Tran, R. Bettencourt, Y. Itahana, P.-Y. Desprez, and S. F. Konieczny
Identification of a Basic Helix-Loop-Helix Transcription Factor Expressed in Mammary Gland Alveolar Cells and Required for Maintenance of the Differentiated State
Mol. Endocrinol., September 1, 2006; 20(9): 2187 - 2198.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N.-S. Kim, H.-J. Kim, B.-K. Koo, M.-C. Kwon, Y.-W. Kim, Y. Cho, Y. Yokota, J. M. Penninger, and Y.-Y. Kong
Receptor Activator of NF-{kappa}B Ligand Regulates the Proliferation of Mammary Epithelial Cells via Id2
Mol. Cell. Biol., February 1, 2006; 26(3): 1002 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. C. Mallory, G. Crudden, A. Oliva, C. Saunders, A. Stromberg, and R. J. Craven
A Novel Group of Genes Regulates Susceptibility to Antineoplastic Drugs in Highly Tumorigenic Breast Cancer Cells
Mol. Pharmacol., December 1, 2005; 68(6): 1747 - 1756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. L. Grimm, A. Contreras, M.-H. Barcellos-Hoff, and J. M. Rosen
Cell Cycle Defects Contribute to a Block in Hormone-induced Mammary Gland Proliferation in CCAAT/Enhancer-binding Protein (C/EBP{beta})-null Mice
J. Biol. Chem., October 28, 2005; 280(43): 36301 - 36309.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Itahana, J. Singh, T. Sumida, J.-P. Coppe, S. Parrinello, J. L. Bennington, and P.-Y. Desprez
Role of Id-2 in the Maintenance of a Differentiated and Noninvasive Phenotype in Breast Cancer Cells
Cancer Res., November 1, 2003; 63(21): 7098 - 7105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. M. Siegel, W. Shu, and J. Massague
Mad Upregulation and Id2 Repression Accompany Transforming Growth Factor (TGF)-{beta}-mediated Epithelial Cell Growth Suppression
J. Biol. Chem., September 12, 2003; 278(37): 35444 - 35450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society